What is the survival rate of a person with stage 3 lymphoma without any treatment? - hodgkins lymphoma survival rate chart
My mother was diagnosed with non-Hodgkin's lymphoma, but they do not want to continue treatment. What is the typical prognosis. In other words, live, how long we expect? His lungs began to fill with fluid and tumors in the lungs too. Thanks for all the information so that (daughter) can be prepared for me and my family. :-)
Hodgkins Lymphoma Survival Rate Chart What Is The Survival Rate Of A Person With Stage 3 Lymphoma Without Any Treatment?
4 comments:
My husband died 4 years ago with the NHL ... It was a par 4 and was treated in Houston. He survived 5 years (this figure was given by doctors in Houston and the sites of cancer). BUT
After living with this disease for over five years, I have men and women diagnosed with Stage 3 a.m. to 4 p.m. and are still alive - known 10-15 years of survival.
I am like your mother, if anything, he was diagnosed with lymphoma would not go for treatment. The side effects are terrible and does the quality of life. The dark clouds are hanging over your head and your loved ones.
Many doctors and nurses will agree with me, but to their relatives in their lives, day after day .... To have the last word.
Give your mother everyInformation that can manipulate the ...
In my opinion, is his mother in the second to the last stages of cancer. Most patients refuse treatment because it is often painful and tiring .. and not to reverse a disease. It seems they want to enjoy the last years of his life, family and friends to spend, do not buy the treatment centers.
Love your mom, make photo albums and are glad they were able to spend many years of his life with her.
God Bless!
There are about 30 types of NHL, with different treatment and prognosis. Regardless of what kind of mother of the lung is not a good sign. I wish you could say why you do not want the treatment. Denied death by cancer is often treated as an ugly death by cancer in whom treatment has no benefit when treatment was for his family. It is a moment where a person may refuse treatment for all the right reasons, but made no statement as to whether his mother is at this stage and given the description of the treatments that have already failed.
After meeting people with 'incurable Level 4 from the NHL who are completely cured of bone marrow or stem cell transplant is all I have to say that mothers should join a complementost of your group type of non-Hodgkin's lymphoma, and talk to people on the same stage, and the diseases they do not give up and continue fighting. This could be the spirit of his mother over things. Are you depressed? Many cancer patients go through a deep depression, and it may make wrong decisions. Depression can be treated.
http://www.cancer.org/docroot/MBC/conten ...
I died a friend with stage 4 lymphoma, because he appointed with Dr. angry and decided not to see a doctor who has been very successful back in the treatment of their disease. It was never able to explain why he was so enraged against the doctor and why it meant that he was leaving for a successful treatment. His arrest is certainly not for the doctor was furious. He did not know late returnDr. NT, if things went badly. He lived over 18 months of his anger and death. I was in my head, there are reasons to die.
I hope that things for your mother do it differently, and if no effective treatment for them to further good use. I suggest you go to a clinic lymphoma MD Anderson for a second opinion on his condition. If you do not choose to be involved to help hospice in their care. This page will help you to resources for palliative care in their community, would be useful in addition to additional guidance.
http://www.hospicenet.org/index.html
http://www.hospicenet.org/html/preparing ...
Good luck to you all
The Non-Hodgkin-Lymphoma (NHL) describes a group of tumors consisting of lymphocytes, a type of white blood cells. The NHL is of Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior and different treatment. Non-Hodgkin's lymphomas are a heterogeneous group of disorders with different courses, treatments and prognosis.
The Non-Hodgkin's lymphoma can in any organ associated with the lymphatic system (develop) such as the spleen, lymph nodes and tonsils. In most cases begins with infiltration of lymph nodes are limited but some subtypes of May to the other lymphoid organs. The diagnosis of non-Hodgkin's lymphoma requires a biopsy of affected tissue. Many subtypes of non-Hodgkin's lymphoma, are also grouped into three different categories on their aggressiveness. These categories are indolent (or low quality), aggressive (or) intermediate grade) and aggressive (or high grade. Treatment of low grade or indolent lymphoma, may begin a period of observation, while aggressive or highly aggressive non-Hodgkin's lymphoma is usually with chemotherapy and / or radiotherapy are treated.
"Phase III" indicates that the cancer has spread to both sides of the membrane, as an institution or in the vicinity of the lymph nodes and spleen.
The most important factor in the overall standings prognosis is the grade or aggressiveness of lymphoma. Indolent (low grade), non-Hodgkin's lymphoma is usually not curable, but usually slowly progressive and responds temporarily to therapy. Aggressivegrade and aggressive (intermediate and high), the NHL will be cured with combination chemotherapy. The long-term survival or cure rates of these diseases, there are a number of prognostic factors.
The International Prognostic Index, or IPI, is the system most widely used estimates for the NHL. This system uses 5 factors:
Age
Lactate Dehydrogenase (blood test)
Performance Status
Clinical phase
Sites of extra nodal disease
It should be noted is that the IPI was developed prior to the introduction of rituximab. As rituximab has become a standard therapy for B-cells in the NHL, the impact on the prognostic value of IPI clear.
The International Prognostic Index (IPI)is a tool of clinical oncologists developed to predict the prognosis of patients with non-Hodgkin's lymphoma. Before 1993's, when the IPI was developed, the primary consideration in assessing the prognosis the scene of Ann Arbor have been alone, but more suitable for a way to predict the outcome of survival have been investigated and therefore other factors .
A retrospective analysis was performed in 2031 patients with non-Hodgkin's lymphoma, all ages, with a regime of doxorubicin-CHOP chemotherapy from 1982 to 1987 based treatment carried out. [1] Several patient characteristics were analyzed to determine whether they were linked to differences in the survival and as important factors in addition to Ann ArborStep: age, lactate dehydrogenase (LDH), performance status and the number of extra-nodal sites of disease.
Post a Comment